Literature DB >> 21272951

The utility of hemoglobin A1c at diagnosis for prediction of future glycemic control in children with type 1 diabetes.

Vidhya Viswanathan1, M Rhonda Sneeringer, Adam Miller, Erica A Eugster, Linda A DiMeglio.   

Abstract

INTRODUCTION: We evaluated the relationships of hemoglobin A1c (A1c) at diagnosis of type 1 diabetes (T1DM) to future glycemic control and to a series of clinical variables in children with T1DM.
MATERIALS AND METHODS: Patients <18 years old diagnosed with T1DM during a one year period who had an A1c at diagnosis and at least one follow-up visit at our center were eligible for inclusion. Baseline variables examined included age, race, gender, symptom duration, admission acuity, anthropometrics, bicarbonate, and A1c. Annual anthropometric and A1c data were also obtained from clinic visits through 4 years after diagnosis.
RESULTS: We identified 120 children (53 males). Mean age at diagnosis was 7.6±3.9 years. Mean A1c at diagnosis was 10.9±1.9%. A1c at diagnosis correlated with age at diagnosis, symptom duration, and A1c at 3-years, with trends towards correlations at 6 weeks and 4 years. A1c at 1 year correlated highly with A1c at subsequent visits. No other baseline variables correlated with subsequent glycemic control.
CONCLUSIONS: In children with newly diagnosed diabetes, A1cs at diagnosis and one year post diagnosis are related to subsequent glycemic control. Children with high A1cs particularly at one year post diagnosis may benefit from targeted intensification of resources.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272951      PMCID: PMC4070008          DOI: 10.1016/j.diabres.2010.12.032

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  14 in total

1.  Glycemic control in youth with type 1 diabetes: family predictors and mediators.

Authors:  Danny C Duke; Gary R Geffken; Adam B Lewin; Laura B Williams; Eric A Storch; Janet H Silverstein
Journal:  J Pediatr Psychol       Date:  2008-02-23

2.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

3.  The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus.

Authors:  Krishnavathana Hassan; Robert Loar; Barbara J Anderson; Rubina A Heptulla
Journal:  J Pediatr       Date:  2006-10       Impact factor: 4.406

4.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

Authors: 
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

5.  Clinical characteristics of insulin-dependent diabetes mellitus in children at diagnosis.

Authors:  L A Proos; M Kobbah; T Tuvemo
Journal:  Ups J Med Sci       Date:  1997       Impact factor: 2.384

6.  Characteristics at diagnosis of type 1 diabetes in children younger than 6 years.

Authors:  Maryanne Quinn; Amy Fleischman; Bernard Rosner; Daniel J Nigrin; Joseph I Wolfsdorf
Journal:  J Pediatr       Date:  2006-03       Impact factor: 4.406

7.  Appointment adherence and disparities in outcomes among patients with diabetes.

Authors:  Joel M Schectman; John B Schorling; John D Voss
Journal:  J Gen Intern Med       Date:  2008-07-26       Impact factor: 5.128

8.  Clinical consequences of the Diabetes Control and Complications Trial.

Authors:  B J Ginsberg; R Mazze
Journal:  N J Med       Date:  1994-04

9.  A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS.

Authors:  Lena Hanberger; Ulf Samuelsson; Bengt Lindblad; Johnny Ludvigsson
Journal:  Diabetes Care       Date:  2008-01-30       Impact factor: 19.112

10.  Predicting metabolic control in the first 5 yr after diagnosis for youths with type 1 diabetes: the role of ethnicity and family structure.

Authors:  Maureen A Frey; Thomas Templin; Deborah Ellis; James Gutai; Cheryl-Lynn Podolski
Journal:  Pediatr Diabetes       Date:  2007-08       Impact factor: 4.866

View more
  6 in total

1.  Long-term glycemic control as a result of initial education for children with new onset type 1 diabetes: does the setting matter?

Authors:  Susanne M Cabrera; Nayan T Srivastava; Jennifer M Behzadi; Tina M Pottorff; Linda A Dimeglio; Emily C Walvoord
Journal:  Diabetes Educ       Date:  2013-02-20       Impact factor: 2.140

2.  The relationship between maternal fear of hypoglycaemia and adherence in children with type-1 diabetes.

Authors:  Evril Freckleton; Louise Sharpe; Barbara Mullan
Journal:  Int J Behav Med       Date:  2014

3.  Early markers of glycaemic control in children with type 1 diabetes mellitus.

Authors:  Samuel W Cutfield; José G B Derraik; Peter W Reed; Paul L Hofman; Craig Jefferies; Wayne S Cutfield
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

4.  Good glycemic control without exceeding the BMI trajectory during the first 5 years of treatment in children and adolescents with type 1 diabetes.

Authors:  Annika Grönberg; Per-Ola Carlsson
Journal:  Pediatr Diabetes       Date:  2022-01-19       Impact factor: 3.409

5.  Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis.

Authors:  Krishnarajah Nirantharakumar; Nuredin Mohammed; Konstantinos A Toulis; G Neil Thomas; Parth Narendran
Journal:  Diabetologia       Date:  2018-02-24       Impact factor: 10.122

6.  Factors predicting poor glycemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: Analyses using mixed effects fractional polynomial models.

Authors:  Veena Mazarello Paes; Jessica K Barrett; David B Dunger; Evelien F Gevers; David C Taylor-Robinson; Russell M Viner; Terence J Stephenson
Journal:  Pediatr Diabetes       Date:  2019-12-17       Impact factor: 4.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.